Medicare Expedites Coverage of Compression Pumps for Lymphedema

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 10 No 7
Volume 10
Issue 7

BALTIMORE, Md-Medicare will expedite coverage of pneumatic compression pumps for its beneficiaries with lymphedema. The new policy provides coverage for the pumps after a beneficiary undergoes conservative therapy, including elevation, exercise, and the use of a compression garment for a least 4 weeks without beneficial results. The new coverage eliminates the need for patients to buy a more expensive, custom-made compression garment before becoming eligible for a pump.

BALTIMORE, Md—Medicare will expedite coverage of pneumatic compression pumps for its beneficiaries with lymphedema. The new policy provides coverage for the pumps after a beneficiary undergoes conservative therapy, including elevation, exercise, and the use of a compression garment for a least 4 weeks without beneficial results. The new coverage eliminates the need for patients to buy a more expensive, custom-made compression garment before becoming eligible for a pump.

Newsletter

Stay up to date on recent advances in the multidisciplinary approach to cancer.

Recent Videos
5 experts are featured in this series
2 experts are featured in this series.
5 experts are featured in this series
2 experts are featured in this series.
Taletrectinib showed improved efficacy in patients with ROS1-positive non–small cell lung cancer who were treatment-naïve.
“It’s a drug that I’m very comfortable with, and it is a drug I’ll likely use primarily in the first-line setting,” stated Jorge Nieva, MD, on taletrectinib in non–small cell lung cancer.
4 experts in this video
4 experts in this video
Those being treated for peritoneal carcinomatosis may not have to experience the complication rates or prolonged recovery associated with surgical options.
For patients with peritoneal carcinomatosis, integrating PIPAC into a treatment regimen does not interrupt their systemic therapy.